סימבקסון 40

Страна: Израиль

Язык: иврит

Источник: Ministry of Health

Активный ингредиент:

SIMVASTATIN

Доступна с:

DEXCEL PHARMA TECHNOLOGIES LTD

код АТС:

C10AA01

Фармацевтическая форма:

קפליות

состав:

SIMVASTATIN 40 MG

Администрация маршрут:

פומי

Тип рецепта:

מרשם נדרש

Производитель:

DEXCEL LTD, ISRAEL

Терапевтическая группа:

SIMVASTATIN

Терапевтические области:

SIMVASTATIN

Терапевтические показания :

Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia Simvaxon is indicated to: - Reduce the risk of total mortality by reducing coronary death - Reduce the risk of non-fatal myocardial infarction - Reduce the risk for undergoing myocardial revascularization procedures - Reduce the risk of stroke and transient ischemic attacks (TIA's). Hyperlipidemia: Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C LDL-C Apo B and TG and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvaxon therefore lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hype

Обзор продуктов:

Atorvastatin, Cerivastatin, Fluvastatin, Lovastatin, Pravastatin, Simvastatin

Дата Авторизация:

2020-04-30